CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Weinberg Eric See remarks | Option exercise | +35,168 | $4.34 | $153K | 235,516 |
| 2026-09-15 | Weinberg Eric See remarks | Option exercise · Stock Option (right to buy) | −35,168 | 0 | ||
| 2026-09-05 | Wilterding Mark Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −258,770 | 0 | ||
| 2026-09-05 | Wilterding Mark Chief Financial Officer | Grant or award · Stock Option (right to buy) | +258,770 | 258,770 | ||
| 2026-09-05 | Weinberg Eric See remarks | Returned to the company · Stock option (right to buy) | −87,437 | 0 | ||
| 2026-09-05 | Weinberg Eric See remarks | Returned to the company · Stock Option (right to buy) | −95,000 | 0 | ||
| 2026-09-05 | Weinberg Eric See remarks | Returned to the company · Stock Option (right to buy) | −92,200 | 0 | ||
| 2026-09-05 | Weinberg Eric See remarks | Returned to the company · Stock Option (right to buy) | −50,000 | 0 | ||
| 2026-09-05 | Weinberg Eric See remarks | Returned to the company · Stock Option (right to buy) | −125,000 | 0 | ||
| 2026-09-05 | Weinberg Eric See remarks | Grant or award · Stock Option (right to buy) | +65,742 | 65,742 | ||
| 2026-09-05 | Weinberg Eric See remarks | Grant or award · Stock Option (right to buy) | +82,608 | 82,608 | ||
| 2026-09-05 | Weinberg Eric See remarks | Grant or award · Stock Option (right to buy) | +59,483 | 59,483 | ||
| 2026-09-05 | Weinberg Eric See remarks | Grant or award · Stock Option (right to buy) | +32,258 | 32,258 | ||
| 2026-09-05 | Weinberg Eric See remarks | Grant or award · Stock Option (right to buy) | +93,984 | 93,984 | ||
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Returned to the company · Stock option (right to buy) | −338,819 | 0 | ||
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Returned to the company · Stock Option (right to buy) | −200,000 | 0 | ||
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Returned to the company · Stock Option (right to buy) | −149,000 | 0 | ||
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Returned to the company · Stock Option (right to buy) | −215,000 | 0 | ||
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +254,751 | 254,751 | ||
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +173,913 | 173,913 |
Page 1 of 15 · 300 trades